Anavex COO Felix Lauscher departs May 11 amid reorganization after interim CEO

ANAVEX LIFE SCIENCES CORP.

Felix Lauscher, COO since March 1, 2026, left Anavex on May 11, 2026.
Departure part of broader reorganization after appointing Dr. Terrie Kellmeyer as Interim CEO.
Lauscher had $264K annual base salary; received prorated pay for service period.
Of 50,000 stock options granted, 45,833 forfeited; 4,167 vested at $4.69/share exercisable until Aug 9, 2026.
Offered two weeks' additional compensation at base salary in exchange for general release.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.